Real-time Product Visibility.
Anytime, Anywhere

The Top Floor - Acsis Company Blog

Sharing our thoughts on the current state of supply chain management, serialization, recalls and other issus in the industry , ser

Proper Product Recalls Protect Customer Loyalty

The demand for track and trace products has never been greater. Recent product recalls, while unfortunate, serve as perfect examples as to why companies need to start having unique identifiers on all products. Read more here.
Pfizer Shines Spotlight on Counterfeit Drugs
· Product Safety | · Serialization

Pfizer has released a series of videos showing just how easy it is for counterfeiters to trick consumers into buying their sub-par (and often life-threatening) products. From horrible manufacturing conditions to fake online pharmacies, see how counterfeiters are putting innocent people’s lives at risk. Educate yourself on the dangers of these products today.
Counterfeit Drug Seizures on the Rise in 2011 – A Silver Lining
· Product Safety | · Supply Chain Optimization | · Serialization

US Customs had their hands full last year between diversion, theft, and other malicious supply chain disruptions. However, no one was hit harder than the Pharmaceutical Industry. The high number of seized counterfeit drugs last year is alarming – but there is a silver lining.
The Top Three Asset Tracking Horror Stories
· Product Safety | · Supply Chain Optimization | Business Solutions

The consequences of losing capital assets across the supply chain has never been greater. Despite the obvious drain on expenses, what other problems could arise from not having trackable assets? We took a look at three real-world examples where the end result was anything but pretty.
Acsis, Inc. Solves Business Issues Video
· Product Safety | · Recall Management | · Supply Chain Optimization | Business Solutions

Just as there are a number of problems plaguing todays supply chain, there are also a number of solutions. In this video, see how Acsis, Inc. solves many of these business issues, including chargebacks, counterfeit products, diversion, parallel trade, and poorly planned product recalls.